SILAC-based quantification reveals modulation of the immunopeptidome in BRAF and MEK inhibitor sensitive and resistant tumor cells
Melissa Bernhardt, Anne Rech, Marion Berthold, Melina Lappe, Jan-Niklas Herbel, Florian Erhard, Annette Paschen, Bastian Schilling, Andreas Schlösser
This study uses SILAC-based quantification to analyze how MAPK inhibitors affect the immunopeptidome in melanoma cells, identifying potential targets for immunotherapy.
Frontiers in Immunology · Jan 6, 2025Peer-reviewedImmunology